Short answer · Medically reviewed summary · Last updated: 2026-04-06
The primary cause of systemic mastocytosis is a somatic mutation in the KIT gene, while the underlying etiology of Mast Cell Activation Syndrome (MCAS) remains largely idiopathic and is still being actively investigated by the global research community. Genetic Factors and Mechanisms In most patients with systemic Mastocytosis, a specific genetic "typo" occurs in the KIT gene, most commonly the D816V mutation. Think of this mutation as a broken "off" switch for a mast cell; instead of waiting for a signal to release chemical mediators, the cell is constantly signaled to grow and accumulate abnormally.
3 people with Mastocytosis and MCAS have shared their first-person experience on this question at DiseaseMaps.
Which are the causes of Mastocytosis and MCAS?
Causes of Mastocytosis and MCAS explained: genetic and environmental factors, reviewed against medical sources, plus patient perspectives.
The primary cause of systemic mastocytosis is a somatic mutation in the KIT gene, while the underlying etiology of Mast Cell Activation Syndrome (MCAS) remains largely idiopathic and is still being actively investigated by the global research community.
Genetic Factors and Mechanisms
In most patients with systemic Mastocytosis, a specific genetic "typo" occurs in the KIT gene, most commonly the D816V mutation. Think of this mutation as a broken "off" switch for a mast cell; instead of waiting for a signal to release chemical mediators, the cell is constantly signaled to grow and accumulate abnormally. In contrast, MCAS is characterized not by an overproduction of cells, but by mast cells that are hyper-responsive—essentially, they have a "hair-trigger" sensitivity to stimuli that would not bother a healthy immune system.
Environmental Triggers and Risk Factors
While the genetic mutation drives Mastocytosis, the symptoms of both conditions are heavily influenced by environmental triggers. These can include physical stress, temperature changes, certain medications (such as NSAIDs or contrast dyes), insect stings, and specific foods. It is vital to distinguish between a cause (the underlying genetic or biological driver) and a trigger (the environmental factor that causes the mast cells to dump their contents, leading to symptoms). While we understand the genetic driver of Mastocytosis well, we are still researching the specific genetic or epigenetic factors that predispose individuals to MCAS.
Current Research Directions
Medical research into Mastocytosis and MCAS is currently focused on identifying secondary genetic markers that may explain why some patients exhibit severe symptoms while others remain stable. Researchers are also investigating the role of the microbiome and potential autoimmune pathways that might lower the activation threshold of mast cells in MCAS. We are moving toward a more personalized medicine approach, where understanding the specific signaling pathways involved in each patient’s unique case helps guide targeted therapeutic interventions.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD) - Mastocytosis
- Orphanet: The portal for rare diseases and orphan drugs
- The American Academy of Allergy, Asthma & Immunology (AAAAI)
- Online Mendelian Inheritance in Man (OMIM) - KIT Gene
Posted Sep 30, 2017 by Meredith 2000
Posted Dec 9, 2019 by Gramarye 700
Posted Mar 3, 2017 by elsa oliveira 1000
